This article is more than 5 years old. Information may no longer be current.
Penn, CHOP to open blood disease center
Click Here to Manage Email Alerts
Penn Medicine intends to establish the Philadelphia region’s first dedicated center for the treatment and research of blood diseases.
The Penn-CHOP Blood Center for Patient Care and Discovery will include a multidisciplinary team of experts capable of providing care for patients with sickle cell disease, thalassemia, bone marrow failure, and bleeding and clotting disorders.
Members of the Perelman School of Medicine hematology faculty from Penn Medicine and Children’s Hospital of Philadelphia will work with physicians, scientists, pharmacologists and investigators from several institutions, including Penn’s Abramson Cancer Center, the Institute of Translational Medicine and Therapeutics, and the Penn Cardiovascular Institute.
Charles Abrams
“Care for blood disorders spans many different areas of medicine, but patients with these illnesses are often not able to access or coordinate the range of specialists needed to best manage their care,” Charles Abrams, MD, who will serve as director of the new blood center, said in a press release. “Penn Medicine’s expertise in both clinical care and research for hematologic conditions provides us with a solid foundation to enhance options for new patients. We hope to serve as a center for research and discovery and as an incubator for the most promising new approaches to preventing, diagnosing and treating these illnesses.”